What is Revelation Biosciences, Inc. Common Stock's Market Cap?

Revelation Biosciences, Inc. Common Stock's Market Cap is $15.1M, based on as-reported figures from SEC (XBRL) filings.

What is Revelation Biosciences, Inc. Common Stock's Enterprise Value?

Revelation Biosciences, Inc. Common Stock's Enterprise Value is $3.6M, based on as-reported figures from SEC (XBRL) filings.

What is Revelation Biosciences, Inc. Common Stock's EV / EBITDA?

Revelation Biosciences, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Revelation Biosciences, Inc. Common Stock's Net Income (TTM)?

Revelation Biosciences, Inc. Common Stock's Net Income (TTM) is -$10.8M, based on as-reported figures from SEC (XBRL) filings.

What is Revelation Biosciences, Inc. Common Stock's EBITDA?

Revelation Biosciences, Inc. Common Stock's EBITDA is -$11.2M, based on as-reported figures from SEC (XBRL) filings.

What is Revelation Biosciences, Inc. Common Stock's Diluted EPS (TTM)?

Revelation Biosciences, Inc. Common Stock's Diluted EPS (TTM) is -2.70, based on as-reported figures from SEC (XBRL) filings.

What is Revelation Biosciences, Inc. Common Stock's Net Debt?

Revelation Biosciences, Inc. Common Stock's Net Debt is -$11.5M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Revelation Biosciences, Inc. Common Stock

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00WH4GC08

3.79▲ 0.11 (2.99%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM): —
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 3.68
Day's Range: 3.66 – 3.88
52-Week Range: 0.44 – 4.06
Volume: 16.3K
Avg Volume: 68.2K

Share Statistics

Shares Outstanding
Employees: 9
Exchange: XNAS
Listed: 2022-01-11

Share count as of August 3, 2026

Revelation Biosciences, Inc. Common Stock (REVB) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Revelation Biosciences, Inc. Common Stock (REVB)

What is Revelation Biosciences, Inc. Common Stock's Market Cap?: Revelation Biosciences, Inc. Common Stock's Market Cap is $15.1M, based on as-reported figures from SEC (XBRL) filings.
What is Revelation Biosciences, Inc. Common Stock's Enterprise Value?: Revelation Biosciences, Inc. Common Stock's Enterprise Value is $3.6M, based on as-reported figures from SEC (XBRL) filings.
What is Revelation Biosciences, Inc. Common Stock's EV / EBITDA?: Revelation Biosciences, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Revelation Biosciences, Inc. Common Stock's Net Income (TTM)?: Revelation Biosciences, Inc. Common Stock's Net Income (TTM) is -$10.8M, based on as-reported figures from SEC (XBRL) filings.
What is Revelation Biosciences, Inc. Common Stock's EBITDA?: Revelation Biosciences, Inc. Common Stock's EBITDA is -$11.2M, based on as-reported figures from SEC (XBRL) filings.
What is Revelation Biosciences, Inc. Common Stock's Diluted EPS (TTM)?: Revelation Biosciences, Inc. Common Stock's Diluted EPS (TTM) is -2.70, based on as-reported figures from SEC (XBRL) filings.
What is Revelation Biosciences, Inc. Common Stock's Net Debt?: Revelation Biosciences, Inc. Common Stock's Net Debt is -$11.5M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · REVBAs-filed SEC (XBRL) data